Eli Lilly and

LLY · NYSE · USD

$1,142.85Change from previous close: −0.61%Absolute change: −$7.00

Close · October 2, 2026

At a glance

Revenue growth
+44.70%
2025 vs 2024
Net income growth
+94.90%
2025 vs 2024
Net margin
31.7%
2024: 23.5%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets142,283116,576112,476114,935100,92389,38978,71575,60771,87563,94464,00657,916
Current assets64,67254,83555,62962,07149,85441,26132,74031,41530,20425,18925,72723,007
Cash and equivalents8,9505,2827,2689,7923,3763,0933,2683,3693,2242,4602,8192,381
Short-term investments———122170127—149140126109113
Receivables23,47521,13620,11619,13116,42113,90012,93912,02912,9939,87411,09310,095
Inventory16,79314,52913,74412,18011,0149,3117,5897,4606,4826,1025,7734,901
Net property, plant and equipment29,28626,54025,93522,31620,53018,47418,15216,17214,82913,62413,93811,863
Goodwill8,8496,1305,8985,8985,7715,7715,7705,7685,7684,9404,9404,085
Other intangible assets18,1107,3746,5216,4475,9086,0126,1666,5376,6366,7626,9076,782
Long-term investments3,8563,1162,8022,9283,3283,2873,2163,2682,9253,1293,4073,069
Current liabilities47,74136,63435,22840,14139,02030,06828,37624,67427,12118,59827,29321,998
Accounts payable6,1125,0295,3794,2624,0763,4423,2292,8872,9252,4742,5992,435
Long-term debt47,85839,37040,86840,94334,25534,58528,52729,11723,84824,67918,42518,081
Total debt49,62441,59543,86542,57835,88936,11530,45329,93524,64325,362——
Total liabilities108,40485,37885,94191,08582,57473,54264,44361,28658,23951,04653,14346,608
Total equity (incl. minority)33,87931,19826,53523,85118,34915,84714,27214,32113,63612,89710,86411,307
Retained earnings31,89329,51424,47022,25217,37615,10013,54513,62713,17812,55410,31210,310
Minority interest———57.576.282.0—80.773.585.291.887.0